AGENAgenus Inc.

AGEN Stock Price, Valuation & Chart | Agenus Inc.

Compare

$8.090+0.10 (+1.25%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology AGEN intrinsic value AGEN calculated fair value vs price

Overview Financials Dividends Ratios

AGEN Historical price chart

AGEN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization336.89M

PE Ratio3.21

EPS2.52

Trading Volume663.47K

Today's High/Low8.26/7.68

Dividend Yield0.00

52 Week High/Low8.85/2.71

Shares Outstanding41.64M

AGEN Financial Statement

AGEN Analyst ratings

AGEN Analysis & performance metrics

AGEN Company profile

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte…

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and…

AGEN Management team

Name

Position

Garo H. Armen Ph.D.CEO

Founder, Executive Chairman & Chief Executive Officer

Jennifer S. Buell Ph.D.CEO

Director and President & Chief Executive Officer of MiNK Therapeutics

Eric Humes

Chief Quality Officer

Christine M. Klaskin

Vice President of Finance, Principal Financial Officer & Principal Accounting Officer

Stefanie Perna-Nacar

Chief Communications & Government Relations Officer

Alfred Dadson

Chief Manufacturing Officer

Craig WinterCTO

Chief Information Officer

Zack Armen

Head of Investor Relations & Corporate Development

Name

Position

Garo H. Armen Ph.D.CEO

Founder, Executive Chairman & Chief Executive Officer

Jennifer S. Buell Ph.D.CEO

Director and President & Chief Executive Officer of MiNK Therapeutics

Eric Humes

Chief Quality Officer

Christine M. Klaskin

Vice President of Finance, Principal Financial Officer & Principal Accounting Officer

Stefanie Perna-Nacar

Chief Communications & Government Relations Officer

Alfred Dadson

Chief Manufacturing Officer

Craig WinterCTO

Chief Information Officer

Zack Armen

Head of Investor Relations & Corporate Development

Management Team

Garo H. Armen Ph.D.CEO

Founder, Executive Chairman & Chief Executive Officer

Jennifer S. Buell Ph.D.CEO

Director and President & Chief Executive Officer of MiNK Therapeutics

Eric Humes

Chief Quality Officer

Christine M. Klaskin

Vice President of Finance, Principal Financial Officer & Principal Accounting Officer

Stefanie Perna-Nacar

Chief Communications & Government Relations Officer

Alfred Dadson

Chief Manufacturing Officer

Craig WinterCTO

Chief Information Officer

Zack Armen

Head of Investor Relations & Corporate Development

Management

Garo H. Armen Ph.D.CEO

Founder, Executive Chairman & Chief Executive Officer

Jennifer S. Buell Ph.D.CEO

Director and President & Chief Executive Officer of MiNK Therapeutics

Eric Humes

Chief Quality Officer

Christine M. Klaskin

Vice President of Finance, Principal Financial Officer & Principal Accounting Officer

Stefanie Perna-Nacar

Chief Communications & Government Relations Officer

Alfred Dadson

Chief Manufacturing Officer

Craig WinterCTO

Chief Information Officer

Zack Armen

Head of Investor Relations & Corporate Development

Total 8 executives

AGEN Frequently asked questions

What is Agenus Inc. (AGEN) Stock Price?

Current stock price of Agenus Inc. (AGEN) stock is $8.090. The stock price is +1.25% higher in the session. The intraday range can be seen from this page. Volume of Agenus Inc. (AGEN) stock is 663.47K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Agenus Inc. (AGEN) stock price going up or down today?

The stock price of Agenus Inc. (AGEN) can change with earnings, company news, and overall market sentiment. Agenus Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Agenus Inc. stock expensive at its current price?

Whether Agenus Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for AGEN on this page is 3.21. EPS on this page is 2.52. Compare those figures with peers and growth expectations before deciding if the current Agenus Inc. price is justified.

How has the stock price of Agenus Inc. (AGEN) performed historically?

Historical performance for Agenus Inc. (AGEN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how AGEN reacted to past earnings and market events.

Should I buy Agenus Inc. (AGEN) stock, at this price?

Buying Agenus Inc. (AGEN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.